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n both neurons and muscle ﬁbers, speciﬁc mRNAs are
concentrated beneath and locally translated at synaptic
sites. At the skeletal neuromuscular junction, all synaptic
RNAs identiﬁed to date encode synaptic components.
Using microarrays, we compared RNAs in synapse-rich
and -free regions of muscles, thereby identifying tran-
scripts that are enriched near synapses and that encode
soluble membrane and nuclear proteins. One gene product,
LL5
 
 
 
, binds to both phosphoinositides and a cytoskeletal
protein, ﬁlamin, one form of which is concentrated at
I
 
synaptic sites. LL5
 
 
 
 is itself associated with the cytoplasmic
face of the postsynaptic membrane; its highest levels
border regions of highest acetylcholine receptor (AChR)
density, which suggests a role in “corraling” AChRs.
Consistent with this idea, perturbing LL5
 
 
 
 expression in
myotubes inhibits AChR aggregation. Thus, a strategy
designed to identify novel synaptic components led to
identiﬁcation of a protein required for assembly of the
postsynaptic apparatus.
 
Introduction
 
A cardinal feature of the chemical synapse is the existence of a
highly specialized postsynaptic apparatus whose molecular
architecture differs dramatically from that of contiguous, non-
synaptic portions of the cell surface (Sanes and Lichtman,
2001; Sheng and Kim, 2002). To understand synaptic devel-
opment, function, and plasticity, it is important to identify
components of the postsynaptic apparatus, learn how their
distribution is regulated, and determine the roles they play.
A key advance in addressing these issues was the discovery
that some postsynaptic proteins are synthesized locally rather
than (or in addition to) being synthesized at a distant site and
then transported to the synapse. In forebrain neurons, for example,
most protein synthesis occurs in the cell body but specific
subsets of mRNAs are transported to dendritic spines, where
they are translated (Steward, 1983; for reviews see Steward
and Schuman, 2001; Martin and Kosik, 2002). Likewise, at
the skeletal neuromuscular junction (NMJ), RNAs encoding
some postsynaptic proteins are concentrated and translated
directly beneath the postsynaptic membrane (Merlie and Sanes,
1985; Goldman and Staple, 1989; Jasmin et al., 1993, Moscoso
et al., 1995b; Valenzuela et al., 1995; Imaizumi-Scherrer et
al.,  1996; for reviews see Sanes and Lichtman, 1999, 2001;
Chakkalakal and Jasmin, 2003). The mechanism that underlies
localized protein synthesis at the NMJ differs from that in
neurons: RNA localization in muscle results, at least in part,
from transcriptional specialization of the few myonuclei within
the multinucleated muscle fiber that lie beneath the postsynaptic
membrane (Klarsfeld et al., 1991; Sanes et al., 1991; Simon et
al., 1992; for review see Schaeffer et al., 2001). The outcome
is similar in neurons and muscles, however, in that specific
mRNAs are localized to the postsynaptic apparatus.
Identification of these synaptic RNAs provides a means
of identifying proteins likely to be important for synapse
formation or function. Moreover, determining which synaptic
components are synthesized locally is an important step in
understanding how synapse assembly is regulated. In the first
part of this paper, we report results of an expression-profiling
screen designed to identify synaptically enriched RNAs in
muscle. We used the elegant methods of Tietjen et al. (2003) to
amplify RNAs from microdissected NMJs and to compare them
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to RNAs from synapse-free portions of muscle. This comparison
led to identification of several new synaptic transcripts, encod-
ing membrane, cytoplasmic, cytoskeletal, and nuclear proteins.
In the second part of the paper, we describe LL5
 
 
 
, a pro-
tein encoded by one of the synaptic RNAs we identified. LL5
 
 
 
was previously identified in a database search for proteins con-
taining pleckstrin homology (PH) domains, which bind phos-
phoinositides on the inner leaflet of the plasma membrane
(Dowler et al., 2000). Subsequent analysis showed that this
binding is regulated by extracellular signals and that LL5
 
 
 
 also
binds a cytoskeletal, actin-associated protein, filamin (Paranav-
itane et al., 2003), one form of which is concentrated at the
NMJ (Bloch and Hall, 1983; Shadiack and Nitkin, 1991). We
show here that LL5
 
 
 
 is associated with the postsynaptic mem-
brane at the NMJ, that it is concentrated at borders of the
postsynaptic domain as it develops, and that it regulates acetyl-
choline receptor (AChR) aggregation in this domain. We pro-
pose that LL5
 
 
 
 is a regulated link in a multimolecular complex
that corrals AChRs in the postsynaptic apparatus.
 
Results
 
A screen for RNAs at synaptic sites
 
Our aim was to identify polyA
 
 
 
 RNAs selectively associated
with the postsynaptic apparatus at the NMJ. In previous stud-
ies, we and others took advantage of the fact that most synapses
in mammalian muscles are confined to a central “endplate
band” (Fig. 1 A), so that synapse-rich and -free samples can be
generated by cutting the muscle into thirds, perpendicular to
the long axis of the fibers (Hall, 1973; Merlie and Sanes, 1985;
Velleca et al., 1994). However, this strategy is not useful for
global comparisons of gene expression because the NMJ occu-
pies only 
 
 
 
0.1% of each muscle fiber’s surface, so synapses
comprise only a small fraction of the nominally synapse-rich
third. Transcripts that are only severalfold enriched at synapses
or that are present at low abundance are not efficiently detected
in this comparison.
We combined two methods to circumvent this problem.
First, we labeled live diaphragm muscles with rhodamine-
 
 
 
-bungarotoxin (rBTX) to visualize the AChRs concentrated
at synaptic sites and microdissected small groups of closely
spaced NMJs (Fig. 1, B and C). In parallel, we dissected re-
gions of equivalent size from completely synapse-free regions
of the same muscles. The extent to which the dissection en-
riched synaptic samples can be estimated from counts of nu-
clei. In mouse diaphragm, about half of all nuclei are within
muscle fibers; the others are in satellite cells, fibroblasts, capil-
lary endothelial cells, and Schwann cells. Each muscle fiber
contains 
 
 
 
500 nuclei, of which approximately five are synapse
associated (Merlie and Sanes, 1985). Thus, in the central third
of the muscle, 
 
 
 
1.5% (5/[1/3 
 
 
 
 1000]) of all nuclei are synap-
tic myonuclei. In the synaptic sample in Fig. 1 (C and D) there
were 21 NMJs and 198 nuclei, so 
 
 
 
50% of nuclei were synap-
tic, a 
 
 
 
30-fold improvement over the previous method.
Second, we used the amplification method of Tietjen et
al. (2003) to prepare targets for hybridization to microarrays.
After amplification, sample quality was assessed by Southern
blotting for four transcripts known to be enriched in synaptic
areas (the AChR 
 
 
 
-subunit, acetylcholinesterase [AChE], the
protein kinase A RI
 
 
 
 subunit [PKARI
 
 
 
], and the muscle spe-
cific kinase [MuSK]; references in Introduction), as well as two
broadly expressed genes (glyceraldehyde-3-phosphate dehy-
drogenase [GAPDH] and cyclophilin). Pairs of samples were
selected in which: (a) the synaptic sample was rich in products
amplified from the synaptic genes, (b) the nonsynaptic sample
contained little or none of these products, and (c) both samples
had nearly equivalent levels of the broadly expressed genes
(Fig. 1 E). Of 
 
 
 
100 pairs analyzed, the nine that best fulfilled
these criteria were hybridized to Affymetrix Murine U74A, B,
and C GeneChips, which together contain 36,701 probe sets.
As a first test of the method, we calculated the synaptic
enrichment of the six transcripts for which there was the best
Figure 1. Isolation of synaptic and nonsynaptic samples from muscle.
(A) Diaphragm muscle stained with rBTX and viewed under a fluorescence
dissecting microscope. Fibers run from top to bottom. NMJs are in a central
“endplate band.” (B) Higher-magnification view of the endplate band
shows that small groups of NMJs are tightly clustered. Synaptic samples for
microarray analysis were obtained by microdissecting groups such as the
one boxed in A and B. (C and D) Microdissected synaptic sample, double-
stained with rBTX (C) and the nuclear stain DAPI (D). Bars: (A) 1 mm;
(B) 200  m; (C and D) 100  m. (E) Southern analysis of two nonsynaptic
(lanes 1 and 2) and two synaptic (lanes 3 and 4) samples after reverse tran-
scription and PCR amplification. Gel was stained with ethidium bromide
(EtBr) to verify equal loading. Blots were probed for transcripts known to
be synaptically enriched (AChR , AChE, PKARI  [PKA], and MuSK) or
presumed to be uniformly distributed (cyclophilin [cycloph.] and GAPDH). 
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prior evidence of synaptic enrichment. Four of these (AChR
 
 
 
,
AChE, PKARI
 
 
 
, and MuSK) had been used for prescreening
by Southern analysis, but the other two (AChR
 
 
 
 and AChR
 
 
 
)
had not. Enrichment of each transcript was calculated as the ra-
tio of the synaptic to extrasynaptic expression levels (Table S1,
available at http://www.jcb.org/cgi/content/full/jcb.200411012/
DC1) and as the rank order of the synaptic/nonsynaptic ratios
(Table I). All but 1 of the 54 ratios (6 genes 
 
 
 
 9 pairs) were 
 
 
 
1
(normalization set the mean ratio equal to 1), and all but the cor-
responding one rank order were above the mean of 18,350
(36,701/2). Both distributions were highly nonrandom (P 
 
 
 
10
 
 
 
14
 
; binomial test). Moreover, the geometric mean of ratios of
these six control genes and the arithmetic mean of their rank or-
der (Table S1 and Table I, bottom row) were much higher than
expected by chance (P 
 
  
 
0.03 for pair No. 3 and P 
 
  
 
0.0006 for
all other pairs; computed using bootstrapping tests). Ratios and
rank orders for the transcripts that had been used for prescreen-
ing were not better than those that had not.
Although known synaptically enriched transcripts ranked
high in each GeneChip pair, only a small fraction of the
transcripts with high ratios or rank orders were likely to be
synaptically enriched, owing to method-derived noise and nat-
ural variation among samples. When we combined results
from multiple pairs, however, a dramatically different picture
emerged. The last column of Table I shows combined rankings
for all nine pairs for the six control genes (calculated as S
 
1
 
/E
 
1
 
  
 
S
 
2
 
/E
 
2
 
...S
 
9
 
/E
 
9
 
). The improved quality of the pooled data can
be seen by comparing it with the mean rank orders of genes for
the nine pairs taken individually. For example, the mean rank-
ings for the AChR
 
 
 
 and 
 
 
 
 subunits are 50 and 654, respec-
tively, whereas those for the pooled ranking are 1 and 2. We
also pooled results by dividing the sum of all synaptic scores
by the sum of all nonsynaptic scores (S
 
1 
 
  
 
S
 
2
 
...S
 
9
 
/E
 
1 
 
  
 
E
 
2
 
...E
 
9
 
)
and by using the significance analysis of microarrays (SAM)
method (Tusher et al., 2001), but these methods gave slightly
lower rank orders than the multiplicative method (unpublished
data) and were not used further. Our method of ranking genes
by geometric means of their ratio is equivalent to that indepen-
dently proposed by Breitling et al. (2004), who also found that
nonparametric ranking could outperform the SAM method.
The availability of multiple chip pairs and validated con-
trol transcripts afforded the opportunity to ask how many repli-
cates are needed to obtain reliable rank orders. To this end, we
calculated the mean rank order for the six control transcripts
from each combination of the 36 (9 
 
 
 
 8/2) possible set of two
pairs, each of the 84 (9 
 
 
 
 8 
 
  
 
7/3 
 
 
 
 2) possible sets of three
pairs, and so on. Results are shown in Fig. 2. The two lines en-
veloping the individual points show the best and worst rank or-
ders that could be obtained; the central line shows the mean rank
order (Fig. 2). Three features of the graph are noteworthy. First,
as expected, the overall reliability of the rankings increases with
the number of replicates (Fig. 2, middle line). Second, even
though all pairs provide useful data, there is such great variabil-
ity among them that the reliability of rankings varies manyfold
depending on which particular pairs are considered (Fig. 2, dif-
ference between top and bottom lines). Third, if one can prospec-
tively identify control genes, it is possible to obtain more reliable
data from a subset of the pairs than from all of them (Fig. 2, bot-
tom line). For example, the mean rank order of the six control
genes is 19 for all nine pairs, but 14 for the best six pairs.
 
Identification of novel synaptic 
transcripts
 
We ranked the 36,701 probe sets from the “best” eight pairs of
samples (Table I; Exp. 3 was omitted based on the low ranking
of the six control genes) and asked how many of the top 25 rep-
resented transcripts enriched at synaptic sites. In some cases,
relevant data have been reported previously; for the others, we
 
Table I. 
 
Enrichment of known synaptic mRNAs in synaptic samples
Gene name Exp. 1 Exp. 2 Exp. 3 Exp. 4 Exp. 5 Exp. 6 Exp. 7 Exp. 8 Exp. 9 Mean rank Pooled rank
 
AChR
 
 
 
1 20 1051 176 4 50 16 10 4496 66 654 2
AChR
 
 
 
3631 4775 8096 265 565 874 11596 3154 83 3671 21
AChR
 
 
 
83 36 80 5 18 88 18 6 119 50 1
MuSK 8801 3624 30131 47 1807 405 29 1490 4271 5623 20
AChE 8458 14475 18126 3488 1062 743 64 4872 6513 6422 54
PKARI
 
 
 
1046 8579 3298 1571 329 208 4957 3250 968 2690 18
Mean 3673 5423 9985 897 639 389 2779 2878 2003 3185 19
 
Probe sets for six synaptic genes were ranked each in microarray pairs by calculating ratio of signal in synaptic sample to that in extrasynaptic sample, and then
ranking ratios of all 36,701 probe sets. None of the mean rank orders (calculated for each chip or for each gene) are in the top 25, but when signals were pooled
and then ranked (see text), five out of six genes ranked in the top 25.
Figure 2. Extent to which replicate sampling enhances reliable detection
of synaptic transcripts. Rank orders for six transcripts known to be synap-
tically enriched (AChR , AChR , AChR , AChE, PKARI , and MuSK) were
calculated for each of nine independent experiments, with the most synap-
tically enriched equal to 1 and the least equal to 36,701 (see Table I). The
mean rank order for all six transcripts was calculated for each combination
of the 36 (9   8/2) possible sets of two pairs, each of the 84 (9   8  
7/3   2) possible sets of three pairs, and so on. The two lines enveloping
the individual points show the best and worst rank orders that could be
obtained from a given number of pairs; central bars shows means. 
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assayed localization with in situ hybridization and/or quantita-
tive RT-PCR (Fig. 3). As summarized in Table II, genes fell
into the following five categories.
 
Known synaptically enriched transcripts,
 
n
 
 
 
 
 
 6. 
 
Of the six transcripts for which evidence of synaptic
localization is strongest (AChR
 
 
 
, AChR
 
 
 
, AChR
 
 
 
, MuSK,
PKARI
 
 
 
, and AChE; see Introduction), all but AChE ranked in
the top 25. A second probe set for AChR
 
 
 
 was also within the
top 25.
 
Known synaptically-enriched proteins,
 
n
 
 
 
 
 
 1. 
 
Nestin, an intermediate filament protein originally
identified in stem cells, is concentrated at the NMJ (Carlsson et
al., 1999; Vaittinen et al., 1999). We find that its RNA is also
enriched at synaptic sites.
 
Genes expressed by Schwann cells, 
 
n
 
 
 
 
 
 3.
 
Motor nerve terminals are ensheathed by Schwann cells, the
glia of the peripheral nervous system. Therefore, synapse-rich
samples used for expression profiling contained Schwann cells,
whereas extrasynaptic samples, isolated from nerve-free re-
gions, were Schwann cell-free. Therefore, we expected that
genes expressed by Schwann cells would be enriched in the
synaptic samples. Consistent with this expectation, three genes
known to be selectively expressed by Schwann cells were
within the top 25 transcripts: the transcriptional regulators
PEA-3 and SOX-10 and the myelin protein zero (Jessen and
Mirsky, 2002).
 
False positives, 
 
n
 
 
 
 
 
 5. 
 
We obtained no evi-
dence that transcripts expressed by five of the probe sets (Table
II, Nos. 4, 7, 15, 17, and 25) were enriched at synaptic sites.
 
Novel transcripts enriched in synaptic
regions, 
 
n
 
 
 
 
 
 10. 
 
Quantitative RT-PCR and/or in situ
hybridization confirmed synaptic enrichment of 10 gene prod-
ucts that had not previously been localized to the NMJ. As
noted above, these transcripts might be expressed by muscle fi-
bers, Schwann cells, or perhaps other synapse-associated cells
(e.g., a specialized perisynaptic population of fibroblasts;
Gatchalian et al., 1989). For five of the mRNAs, in situ hybrid-
ization signals were too weak or diffuse to allow distinction
among these sites (Table II, Nos. 3, 8, 9, 20, and 24). For the
other five, however, in situ hybridization revealed a punctate
pattern of expression associated with individual muscle fibers
(Fig. 3, A and B); this finding was most consistent with local-
Figure 3. Verification of novel synaptic transcripts by whole mount in situ
hybridization and quantitative RT-PCR. (A and B) Neonatal diaphragm
was hybridized with probes for CD24 (A) or LL5  (B). RNA is concen-
trated at discrete sites identified as NMJs based on their number and position
and by histochemical staining of adjacent muscle pieces with rBTX or a
histochemical stain for AChE. Bar, 0.5 mm. (C) Quantitative RT-PCR of
synaptic and extrasynaptic samples. A broadly distributed transcript
(GAPDH, open squares) is present at similar levels in both samples,
whereas dynein intermediate chain (Table II, No. 3; filled squares) is
greater than sixfold enriched in the synaptic sample. Black and gray lines
show data from synaptic and extrasynaptic samples, respectively. Thick
line is the threshold value, used to calculate Ct (threshold cycle), from
which differences between samples were determined.
 
Table II. 
 
Transcripts with highest enrichment in synaptic compared 
with extrasynaptic samples
Rank Ratio UniGene (Mm.) Gene Name Validity
 
1 83.64 4980 AChR
 
 
 
K-R
2 56.78 4583 AChR
 
 
 
1 K-R
3 30.28 79127 Dynein int. chain 1 SY-
 
?
 
4 20.76 291463 Trifunctional enz.-
 
 
 
–
5 18.93 276739 SOX10 SC
6 16.39 29742 CD24 Sy-M
7 16.28 37644 rep seq –
8 15.22 66293 SDR2 Sy-
 
?
 
9 14.91 33268 Ssb4 Sy-?
10 13.32 5025 PEA3 SC
11 12.86 225050 Unc53H3 Sy-M
12 11.63 16148 MuSK K-R
13 11.40 155708 ERM K-R
14 10.88 23742 Nestin K-P
15 10.49 172931 rep seq –
16 10.40 211477 LL5  Sy-M
17 10.14 317642 Serf2 –
18 9.69 124666 NTA Sy-M
19 8.88 4980 AChR  K-R
20 8.63 32648 unnamed Sy-?
21 8.46 30039 PKARI  K-R
22 8.40 2811 AChR  K-R
23 7.67 9986 MPZ SC
24 7.58 295263 Cpg16 Sy-?
25 7.52 335452 noncoding RNA –
Rankings and ratios, calculated as in Table I and Table S1, respectively, are
shown along with UniGene number (http://www.ncbi.nlm.nih.gov) and gene
name. Last column classifies genes: K-R, known to be synaptic at RNA level;
K-P, known to be synaptic at protein level; SC, known to be selectively expressed
by Schwann cells; Sy-M, synaptic mRNA shown by in situ hybridization to be
expressed by muscle in this study; Sy-?, mRNA shown to synaptic by quantitative
PCR, but cell of origin unknown; –, no evidence for synaptic enrichment.LOCALLY TRANSLATED SYNAPTIC COMPONENTS • KISHI ET AL. 359
ization in the postsynaptic apparatus (Moscoso et al., 1995a,b),
although association with Schwann cells cannot be ruled out.
One of these gene products, LL5  (No. 16; Fig. 3 B), is de-
scribed in detail below (see Figs. 4–6). The other four are de-
scribed in the following paragraphs.
The first gene product, CD24 (No. 6), is a small, highly
glycosylated, membrane-associated protein. It has been studied
most intensively in the immune system but is also expressed in
the nervous system, where it has been implicated in the control
of neurogenesis and neurite outgrowth (Calaora et al., 1996; She-
wan et al., 1996; Kleene et al., 2001; Belvindrah et al., 2002).
The second gene product, Unc53H3/neuron navigator
3/ POMFIL1 (No. 11; Coy et al., 2002; Maes et al., 2002; Mer-
rill et al., 2002), is predicted, on the basis of its sequence, to be
a cytoplasmic, actin-binding adaptor protein. It is one of three
mammalian orthologues of Caenorhabditis elegans unc-53.
Unc 53 mutants exhibit defects in axon branching and mus-
cle formation (Hekimi and Kershaw, 1993; Stringham et al.,
2002), and unc53H2-deficient mice show defects in sensory
acuity and optic nerve growth (Peeters et al., 2004).
The third gene product, ERM (No. 13), is a member of a
large family of “Ets-domain” transcriptional regulators (Shar-
rocks, 2001). Ets-domain proteins are believed to promote se-
lective transcription of AChR subunit genes by synaptic nuclei
(Schaeffer et al., 2001). Attention has centered on the Ets-
related proteins GABP-  and - , but both RNAs are present in
extrasynaptic as well as synaptic regions (Fromm and Burden,
1998; Schaeffer et al., 1998), suggesting that additional factors
are involved in limiting GABP-mediated transcription to spe-
cific sites. That Ets-domain factors function as heterodimers
makes it tempting to speculate that ERM plays such a role.
Consistent with this possibility, Hippenmeyer et al. (2002) re-
cently published micrographs suggesting selective localization
of ERM RNA in synaptic regions of embryonic muscle.
Finally, NTA (No. 18) RNA encodes a 217–amino acid
protein conserved in several mammalian species (mouse, rat,
and human; UniGene identifiers are Mm 21836, Rn. 13571, and
Hs. 157779, respectively). This RNA begins just 200 bp 3  to
the last known exon of the AChE gene (Wilson et al., 2001), so
we have given its locus the working name “NTA” for “next to
AChE.” It is unclear whether it represents an alternative tran-
scriptional product of the AChE locus or a distinct gene. Our
data are consistent with both possibilities: Northern analysis us-
ing an NTA-specific probe revealed transcripts of 1.2 and 3.8
kb in muscle, the former excluding and the latter including
AChE-derived sequences (unpublished data). The differential
regulation of NTA and AChE RNAs by innervation (see the fol-
lowing section) also implies the existence of distinct mRNAs.
In summary, of the top 25 genes from our microarray
analysis, the synaptic enrichment of 20 was validated by a sec-
ond method (RT-PCR, in situ hybridization, or published im-
munohistochemical localization). Of these 20, at least five en-
code RNAs that are concentrated very near the NMJ but have
not previously been studied in the context of the NMJ. Remark-
ably, all five are plausible candidates for synaptic roles, based
on their chromosomal localization (NTA), roles in other neural
systems (Unc5h3 and CD24), known properties of synapse-
specific transcription (ERM), or our own data (LL5 ; see Figs.
7 and 8).
The 25 probe sets that we analyzed gave signals that were
 7.5-fold higher in synaptic than in extrasynaptic regions of
muscle. Of the 36,701 probe sets queried, a total of 42, 70, 139,
and 424 showed greater than six-, five-, four-, and threefold
synaptic enrichment, respectively (Table S2, available at
http://www.jcb.org/cgi/content/full/jcb.200411012/DC1). Al-
most surely, the incidence of false positives will increase as the
enrichment decreases. Moreover, some of the true positives
may encode proteins expressed by nonmuscle cells, such as
Schwann cells or perisynaptic fibroblasts. Nonetheless, it
seems likely that the list in Table S2 includes many additional
novel synaptic components.
Coregulation of synaptically enriched 
transcripts
Several RNAs previously shown to be enriched at synaptic
sites—notably the AChR ,  , and   subunits, N-CAM, and
MuSK—share two additional features: their abundance in mus-
cle decreases as development proceeds and increases after den-
ervation (Merlie et al., 1984; Covault et al., 1986; Goldman et
al., 1988; Valenzuela et al., 1995). We asked whether or not
RNAs encoding other components of the postsynaptic appara-
tus are regulated similarly.
First, we determined the synaptic enrichment of tran-
scripts encoding basal lamina, plasma membrane, and cyto-
skeletal proteins concentrated in the postsynaptic apparatus
(Peters et al., 1994; Miner and Sanes, 1994; Altiok et al., 1995;
Moscoso et al., 1995a,b; Zhu et al., 1995; Patton et al., 1997;
Sanes and Lichtman, 1999). In addition to those transcripts
listed in Tables I and II, RNAs encoding AChR , AChR ,
rapsyn, ColQ, erbB3, utrophin, N-CAM, laminins  5, and col-
lagen  3(IV) were enriched in the synaptic samples (Table III).
In contrast, RNAs encoding the basal lamina protein laminin
 2, the membrane protein erbB4, and the cytoskeletal protein
syntrophin   2 were not appreciably enriched in synaptic
mRNA (unpublished data), even though their protein products
are concentrated at synaptic sites.
Second, we asked which synaptically enriched transcripts
are present at higher levels in embryonic (embryonic day 15) or
denervated muscles than in normal adult muscle. For this pur-
pose, we generated new targets by conventional methods that
did not involve amplification. 76% of the synaptically enriched
transcripts queried (16/21) were up-regulated after denerva-
tion, and 81% (17/21) were down-regulated during develop-
ment (Table III). Three genes identified in this study, NTA,
unc53H3, and LL5 , share this pattern.
Synaptic genes are not, however, completely coregulated.
Some variations from the common pattern have been noted
previously, for example the postnatal up-regulation of AChR ,
and the down-regulation of AChE after denervation (Sanes and
Lichtman, 1999). Another pattern is that of ERM RNA, which
changes little during development or after denervation. Synap-
tic nuclei acquire specialized properties during development
and maintain them in denervated muscle. Although AChR sub-
unit genes are selectively transcribed by these nuclei, they areJCB • VOLUME 169 • NUMBER 2 • 2005 360
also transcribed by extrasynaptic nuclei during development
and after denervation. Expression of a gene involved in con-
trolling synapse-specific transcription might be expected to re-
main more confined to synaptic nuclei than expression of the
genes it regulates. Our results are consistent with the idea that
ERM is one such gene.
Synaptic localization of LL5 
The rationale for our screen was that RNAs concentrated in
synaptic areas encode proteins concentrated at synaptic sites.
This idea was plausible but unproven, in that all synaptically
enriched RNAs described to date were identified because their
protein products were already known to be synaptic compo-
nents. Therefore, we asked whether or not a novel gene identi-
fied in our screen, LL5 , encoded a synaptic component.
LL5  is an  160-kD protein containing two predicted
coiled-coil domains, a serine-rich region predicted to contain
multiple protein kinase C phosphorylation sites, and a phos-
phoinositide-binding module called a PH domain. Many PH
domains selectively bind 3-phosphorylated phosphoinositides
that are generated in the inner leaflet of the plasma membrane
by phosphatidylinositol 3-kinase (PI3K); therefore, they serve
to recruit signaling proteins to the membrane in response to
PI3K activation (Lemmon and Ferguson, 2000). Paranavitane
et al. (2003) showed that LL5  binds both phosphatidylinositol
(3,4,5)-triphosphate and a cytoskeletal adaptor protein,  -fil-
amin, and that activation of PI3K regulates its association with
the membrane. Two partial homologues of LL5  are present
in the mouse genome: LL5 , which binds phosphoinositides
(Dowler et al., 2000) but has not been studied further, and a
novel sequence that we found by database searching and call
LL5 . The three members of the LL5 family all have two
coiled-coiled domains and a PH domain, but strong homology
is restricted to their carboxy termini; their amino termini are di-
vergent in both sequence and domain structure (Fig. 4 A). To
date, no physiological role has been reported for any member
of the LL5  family.
To ask if LL5  is synaptically localized, we raised mono-
clonal antibodies to a region with low homology to LL5  and  
Table III. Regulation of synaptic genes during development and after 
denervation
Rank Gene name
Synaptic/
extrasynaptic
Denervation/
adult
Embryonic/
adult
1 AChR  83.64 0.28 0.04
2 AChR 1 56.78 25.35 3.58
6 CD24 16.39 1.93 0.34
11 Unc53H3 12.86 1.35 3.17
12 MuSK 11.63 4.89 7.58
13 ERM 11.40 0.93 0.47
14 nestin 10.88 0.41 4.03
16 LL5  10.40 1.95 4.04
18 NTA 9.69 1.49 2.57
21 PKARI  8.46 1.66 1.08
22 AChR  8.40 2.42 7.12
47 AChE 5.78 0.09 1.95
79 collagen  3(VI) 4.82 1.08 1.58
122 ColQ 4.14 1.15 1.91
307 utrophin 3.28 4.76 2.75
455 AChR  2.95 1.10 19.36
1728 AChR 1 2.13 6.16 1.09
2227 NCAM 1.99 1.77 0.95
2845 laminin  5 1.88 1.35 3.40
4925 rapsyn 1.61 0.50 1.57
7374 ErbB3 1.44 2.83 8.69
Synaptic enrichment of transcripts previously known to encode synaptic proteins
was determined as in Table S1; those with rankings in the top 20% are listed,
along with new genes identified in this study. Changes in abundance during
development and after denervation were assessed with duplicate microarrays.
Figure 4. Structure and synaptic localization of LL5 . (A) Structures of
LL5  and two homologues, LL5  and LL5 . The percentage of amino acid
identity of conserved domains is shown; amino termini of the three gene
products are dissimilar. FHA, forkhead-associated domain; Ser, serine-rich
region; COIL, coil-coil domain; PH, pleckstrin homology domain. (B–D)
Longitudinal sections of adult muscle stained with mAb to LL5  (low magni-
fication, B; high magnification, D) or control antibody of the same isotype
(C) plus rBTX. LL5  is colocalized with AChRs. (E) Cross section of an
adult rat NMJ showing LL5  concentrated in the depths of junctional folds
and between AChR-rich areas at the crests of folds. (F) Synaptic concentration
and colocalization were evident by prenatal day 4. (G) C2 myotubes
were treated with agrin to induce AChR clusters, and then stained with
anti-LL5  and rBTX. LL5  is concentrated at AChR-rich clusters. Bars: (B and C)
100  m; (D) 20  m; (E and F) 5  m; (G) 10  m.LOCALLY TRANSLATED SYNAPTIC COMPONENTS • KISHI ET AL. 361
(see Materials and methods) and used them to stain longitudi-
nal sections of adult mouse and rat muscles. NMJs were selec-
tively stained (Fig. 4, B–D), although nerve bundles and fibro-
blasts were also LL5 -positive (not depicted). Similar results
were obtained with two other antibodies to LL5 , whereas con-
trol antibodies of the same isotype did not stain NMJs. High-
power views of cross sections suggested that the distribution of
AChRs and LL5  was not identical within NMJs: AChRs are
concentrated at the crests of junctional folds (Sanes and Licht-
man, 2001), whereas levels of LL5  were highest in the depths
of junctional folds and between AChR-rich regions (Fig. 4 E).
Substantial colocalization of LL5  and AChRs was evident by
P4 (Fig. 4 F). LL5  was also colocalized with AChR-rich
patches in cultured myotubes (Fig. 4 G).
These results demonstrate an association of LL5  with
the postsynaptic membrane of the NMJ. To ask if the PH do-
main mediates this association, we fused GFP to LL5  or to a
mutant LL5  from which the PH domain had been deleted
(LL5  PH). Expression plasmids encoding GFP-LL5 , GFP-
LL5  PH, or GFP alone were electroporated into mouse ante-
rior tibialis muscles. By 4 d after electroporation, GFP was
colocalized with AChRs in muscle fibers expressing GFP-
LL5  (Fig. 5 A; n   10). In contrast, GFP immunofluores-
cence was diffuse and cytoplasmic in fibers from muscles that
had been transfected with GFP-LL5  PH or GFP alone (Fig.
5, B and C; n   10 each). Likewise, GFP-LL5  but not GFP-
LL5  PH localized to AChR-rich clusters in cultured myo-
tubes (unpublished data). Thus, its PH domain is essential for
targeting LL5  to the NMJ. In contrast, fusion of GFP to iso-
lated PH domains did not localize to AChR clusters in myo-
tubes (unpublished data), indicating that although the PH do-
main is necessary for localization it is not sufficient.
Role of LL5  in AChR clustering
For further analysis of LL5  localization and function, we
used a culture system in which myotubes form elaborate,
branched AChR aggregates that resemble adult NMJs in sev-
eral respects. The aggregates form on the substrate-facing
surface, and can thus be imaged in a single plane; and they
form from simple plaques in a series of steps resembling
those that transform the embryonic NMJ into the adult struc-
ture in vivo (Kummer et al., 2004). They are therefore useful
Figure 5. Synaptic localization of LL5  requires its PH domain. Muscles
were electroporated with the indicated constructs. 4 d later, fibers were
fixed, teased, and stained with rBTX. (A) GFP-LL5  colocalizes with AChRs
at the NMJ. (B and C) A fusion protein lacking the carboxy-terminal PH
domain (GFP-LL5 - PH [B]) and GFP alone (C) are diffusely distributed.
Bar, 20  m.
Figure 6. LL5  is associated with borders of developing AChR clusters.
C2 myotubes were cultured on a laminin substrate to induce development
of complex, branched AChR aggregates, and then double-stained with
anti-LL5  and rBTX. (A) LL5  is colocalized with AChRs in simple plaques
but concentrated at the circumference of the clusters. (B and E) Peripheral
distribution of LL5  becomes more marked as clusters become perforated
and then branched. Bracketed region in E is shown at higher magnification
in F. (C and D) In some cases, LL5  is most concentrated at the borders
of the perforations that transform plaques into annuli and then into
branched aggregates. (F) Within aggregates, AChRs and LL5  have
complementary distributions. (G) High magnification view of an NMJ from
a P7 mouse (Fig. 4 F) showing similar complementarity in vivo. Bars: (A–E)
10  m; (F and G) 1  m.JCB • VOLUME 169 • NUMBER 2 • 2005 362
for following developmental changes in LL5  distribution
that could not be discerned in vivo.
LL5  was associated with AChR-rich plaques in this sys-
tem throughout their evolution, but its distribution differed sys-
tematically from that of AChRs. In simple plaques, AChRs were
uniformly distributed, whereas LL5  was concentrated around
the circumference (Fig. 6 A). Subsequently, as plaques became
perforated at their centers, the peripheral distribution of LL5 
became more marked (Fig. 6 B). In some cases, LL5  also
rimmed the outer circumference of the perforations that trans-
form plaques into annuli and then into branched structures (Fig.
6, C and D). The tendency of LL5  to concentrate at the periph-
ery persisted in branched aggregates but was less striking (Fig. 6
E). Within aggregates, LL5  and AChRs were often distributed
in complementary patterns (Fig. 6 F); the distribution of LL5  is
reminiscent of that of vinculin and dystrophin (Bloch and Pump-
lin, 1988; Dmytrenko et al., 1993). Likewise, LL5  and AChRs
appeared to have complementary distributions at developing
NMJs in vivo (Fig. 6 G), as well as at adult NMJs (Fig. 4 E), al-
though the more favorable geometry of myotube cultures made
details of the localization more readily appreciated in vitro.
To find whether or not LL5  plays a role in AChR clus-
tering, we used RNAi to suppress its expression in myotubes.
Two of four sequences tested effectively suppressed LL5  ex-
pression in heterologous cells (Fig. 7 A and see Materials and
methods). These sequences were used to generate expression
vectors, which were introduced into muscle cells. Both vectors
decreased the level of endogenous LL5  by 40–50% and the
frequency of AChR clustering by  50% compared with un-
treated cultures, whereas control vectors had no significant ef-
fect (Fig. 7, B and C; and not depicted). None of the RNAi vec-
tors had any apparent effect on cluster size or shape.
Given the low transfection efficiency that we and others
have noted for muscle cells, we were surprised that LL5 
RNAi suppressed AChR clustering in so many myotubes.
Therefore, we assayed transfection efficiency with GFP. En-
dogenous GFP fluorescence was detectable in only  10% of
myotubes, but immunostaining with anti-GFP revealed low
levels of expression in an additional  50% of myotubes (Fig. 7
D). We suggest that RNAi vectors are also expressed at low
levels in most myotubes, and that these levels are sufficient to
suppress LL5  function because RNAi acts catalytically. Con-
sistent with this idea, the 40–50% decrease in total LL5  levels
in the myotube cultures implies that levels are decreased by
65–80% in the transfected myotubes.
As a second approach to assessing the function of LL5 ,
we overexpressed GFP-LL5  in myotubes. The fusion protein
was associated with AChR aggregates when it was expressed at
modest levels (unpublished data; levels assessed by staining
with anti-LL5 , and comparing to endogenous levels in con-
trols). In contrast, GFP-LL5  was diffusely distributed in myo-
tubes that expressed high levels of fusion protein, and few
AChR aggregates were present in these myotubes (Fig. 8 A).
Instead, AChRs in these myotubes were distributed diffusely
and in small patches (Fig. 8 A). No perturbations were ob-
served in myotubes expressing GFP alone, the GFP-LL5  PH
fusion protein, or the GFP-PH fusions (Fig. 8, B–D; and not de-
picted), indicating that the effects of the LL5  were specific.
However, lacking another PH domain–containing protein that
localizes to AChR clusters, we cannot rule out the possibility
that the effects of overexpression result from a nonphysiologi-
cal perturbation of the AChR-rich domain.
Discussion
Although much is known about the molecular architecture of the
synapse, it is clear that additional components remain to be dis-
covered. To identify some of them, we exploited the finding that
all of  10 mRNAs previously reported to be concentrated in syn-
aptic regions of muscle fibers encode components of the postsyn-
Figure 7. LL5  is required for AChR clustering.
(A) COS cells were cotransfected with GFP-
LL5  plus control duplex VIII siRNA (left), LL5 -
RNAi#1 (center), or LL5 -RNAi#2 (right), and
then examined for GFP fluoresence. RNAi#1
and #2 suppressed GFP-LL5  expression. (B and
C) Myotubes cultured on laminin (Fig. 6) were
transfected with the indicated RNAi vectors, or
control RNAi vector, fused to form myotubes,
and then stained with rBTX. Both LL5  RNAi’s
decreased the number of AChR aggregates,
whereas control RNAi (a sequence that effec-
tively suppressed GFP) had no effect. (C) Exam-
ples are shown in B and data from one exper-
iment are graphed (C; 15–10  microscope
fields were counted per culture). The differ-
ence between LL5  RNAi and either control
is significant at P   0.001 by t test. Similar
results were obtained in two additional experi-
ments. Western blots of myotube lysates, using
anti-LL5  antibody 7E3, are shown in C
(bottom). Densitometry showed that RNAi#1
and #2 decreased LL5  protein levels by 40–
50% compared with mock-transfected and
control RNAi-transfected cultures. Error bars
show mean   SEM. (D) GFP-transfected myotubes were stained with anti-GFP to show high transfection efficiency. Only the brightest myotubes would
appear positive for endogenous GFP fluorescence. Inset shows mock-transfected myotubes stained with anti-GFP. Bar, 100  m.LOCALLY TRANSLATED SYNAPTIC COMPONENTS • KISHI ET AL. 363
aptic apparatus at the NMJ (Merlie and Sanes, 1985; Goldman
and Staple, 1989; Jasmin et al., 1993, Moscoso et al., 1995b;
Valenzuela et al., 1995; Imaizumi-Scherrer et al., 1996; for re-
views see Sanes and Lichtman, 1999, 2001; Chakkalakal and Jas-
min, 2003). Therefore, we used microarray-based expression
profiling to seek additional synaptic RNAs. By combining micro-
dissection, controlled amplification, sample prescreening, and
multiple replicates, we reduced the false positive rate to  20% for
the top tier of 25 genes, validated 10 novel RNAs enriched in syn-
aptic areas, and provided  200 additional candidates.
Our analysis demonstrates the power of the Tietjen et al.
(2003) method for expression profiling of tiny samples and pro-
vides some guidelines for its use. In particular, our data directly
demonstrate that the amplification method generates high ampli-
tude noise, which obscures enrichment of transcripts. In fact,
most exceptionally high and low values obtained from any single
GeneChip represent noise. Because this noise is more or less ran-
dom, however, it is efficiently diluted when data sets are pooled,
facilitating detection of genes that are consistently enriched,
even if the degree of enrichment is modest.
We also used conventional expression profiling to show
that greater than three fourths of the known and novel synaptic
RNAs are coregulated during development and after denerva-
tion, suggesting the existence of a common regulatory pro-
gram. One cis-element critical for synaptic expression is the
N-box, a site that binds Ets-domain transcription factors; such
sites are already known to play roles in the synaptic transcrip-
tion of genes encoding AChR subunits, AChE, and utrophin
(Koike et al., 1995; Schaeffer et al., 2001). Cis-elements called
E-boxes, which bind basic helix-loop-helix factors, have been
implicated in down-regulation during development and up-reg-
ulation after denervation. Many genes selectively transcribed in
synaptic nuclei may share a set of such cis-elements, as envi-
sioned for members of “synexpression groups” (Niehrs and
Pollet, 1999). However, synaptic genes are not completely co-
regulated. Reasons for the exceptions are unknown, but we
speculate that expression of genes involved in regulating syn-
apse-specific transcription might be more confined to synaptic
nuclei during development and after denervation than expres-
sion of the genes they regulate. ERM may be one such gene.
Figure 8. Overexpression of LL5  perturbs
AChR clustering. Myoblasts cultured on laminin
(Fig. 6) were transfected with the indicated
constructs, fused to form myotubes, and then
stained with rBTX. (A) Few large AChR clusters
are present in myotubes that overexpress GFP-
LL5 ; instead, receptors are present diffusely
and in small patches (arrows). (B and C)
Forced expression of GFP (B) or a GFP-LL5 
fusion protein lacking the PH domain (GFP-
LL5 - PH; C) has no effect on the frequency of
aggregation. Bar, 100  m. (D) Percent of
transfected (strongly fluorescent) or untrans-
fected myotubes with complex AChR aggre-
gates. 80 myotubes were analyzed per condi-
tion: 40 in each of two separate experiments.
Difference between GFP-LL5  and each other
condition is significant at P   0.001. Error
bars show mean   SEM.JCB • VOLUME 169 • NUMBER 2 • 2005 364
All five of the novel RNAs that we showed to be enriched
at or near synaptic sites by in situ hybridization (NTA, Unc5h3,
CD24, ERM, and LL5 ) are reasonable candidates for synaptic
roles. Here, we focused exclusively on one of them, LL5 .
LL5  had previously been shown to bind phosphoinositides
and filamin (Dowler et al., 2000; Paranavitane et al., 2003), but
its localization and physiological function were unknown. We
found that LL5  is a component of the postsynaptic apparatus,
thereby validating our overall strategy. Moreover, detailed
analysis of localization as well as loss- and gain-of-function
analyses showed that LL5  is part of the machinery required
for aggregation of AChRs.
The mechanism by which LL5  affects AChR aggregation
remains to be explored, but some clues exist: (a) LL5  is most
highly concentrated in AChR-poor regions directly adjacent to
AChR-rich regions (edges of clusters and interstices between mi-
croaggregates, in vitro and in vivo: Fig. 4 E; and Fig. 6, F and G).
(b) Its association with the postsynaptic membrane is mediated
by its phosphoinositide-binding PH domain (Fig. 5). (c) It binds
to a cytoskeletal component, filamin (Paranavitane et al., 2003),
one form of which is itself colocalized with clustered AChRs in
myotubes (Bloch and Hall, 1983; Shadiack and Nitkin, 1991). (d)
It can reorganize the cytoskeleton in response to extracellular sig-
nals that regulate its association with the membrane (Paranavi-
tane et al., 2003). (e) AChR-rich and -poor regions within AChR
aggregates differ in their lipid composition (Pumplin and Bloch,
1983; Scher and Bloch, 1991; Barrantes, 2002). Together, these
data suggest a model in which LL5  “corrals” AChRs by form-
ing a dynamic link between specific lipids and the AChR-associ-
ated cytoskeleton; the link would remodel as AChR clusters grow
or change in shape, and might even help direct shape changes.
In this model, corrals would be unable to form when LL5 
is absent, impeding clustering, whereas overexpression of LL5 
might inhibit AChR aggregation by preventing microaggregates
from coalescing into larger clusters. Alternatively, when LL5  is
present in excess, some molecules might bind the cytoskeleton
and others the membrane, disrupting the corraling complex and
leading to a phenotype similar to that seen when LL5  levels are
decreased. The latter explanation is similar to that postulated for
rapsyn, another protein associated with the cytoplasmic face of
the postsynaptic membrane: no AChR clusters form in the ab-
sence of rapsyn (Gautam et al., 1995), but overexpression also
inhibits clustering (Yoshihara and Hall, 1993; Han et al., 1999).
One way to elucidate LL5 ’s mechanism of action will be to
identify the signals that affect its localization or binding capacity
and to ask if it interacts with intracellular pathways already im-
plicated in AChR clustering (Jones and Werle, 2000; Weston et
al., 2000; Luo et al., 2002, 2003; Finn et al., 2003).
Materials and methods
Microarray analysis
To isolate NMJs, diaphragms of C57B1 6J mice were incubated in ice-cold
PBS containing 10  g/ml rBTX (Molecular Probes) for 5 min to stain NMJs,
and then washed with PBS. Clusters of  20 closely spaced NMJs were lo-
cated with a fluorescent dissecting stereomicroscope (model SZX12; Olym-
pus) and cut out using forceps and a micro-knife. Synapse-free samples of
equivalent size were obtained from each muscle and processed in parallel.
These samples were used for cDNA synthesis and PCR amplification as de-
scribed by Dulac and Axel (1995). The cDNAs were assayed by Southern
blotting using the following probes: GAPDH (GenBank/EMBL/DDBJ acces-
sion no. M32599; nt 529–1228), cyclophilin A (GenBank/EMBL/DDBJ
accession no. X52803; 22–708), AChR  (GenBank/EMBL/DDBJ acces-
sion no. M17640; 1148–1825), AChE (GenBank/EMBL/DDBJ accession
no. X56518; 1372–2062), MuSK (GenBank/EMBL/DDBJ accession no.
U37709; 2626–3299), PKARI  (GenBank/EMBL/DDBJ accession no.
BC003461; 2591–3279). Based on results of Southern analysis, probes
were prepared from nine pairs of samples (six from adult and three from P4
animals) by minor modifications of the methods of Tietjen et al. (2003). In
brief, PCR products were reamplified, purified, digested with EcoRI, purified
twice on CHROMA SPIN-200 Columns (CLONTECH Laboratories, Inc.),
fragmented with RQ1 DNase (Promega) for 13 min at 37 C, and biotinyl-
ated with Biotin-N6-ddATP (NEN Life Science Products) and terminal trans-
ferase (Invitrogen) for 90 min at 37 C. The targets were hybridized to Gene-
Chip arrays (Murine U74A, B, and C; Affymetrix, Inc.), which were then
processed as described by Lockhart et al. (1996).
For analysis of gene regulation, we compared lower leg muscles
from day 15 embryos, lower leg muscles from adults 4 d after unilateral
section of the sciatic nerve, and contralateral innervated muscles from the
same mice. Total RNA was isolated with Trizol Reagent (Invitrogen) and
RNeasy Mini Kit (QIAGEN). RNA was converted to double-stranded
cDNA with an oligo(dT) primer containing a T7 promotor and used for
synthesis of biotinylated cRNA using a Bioarray HighYield Kit (Enzo). The
cRNA targets were fragmentated as described previously (Lipshutz et al.,
1999), and then hybridized to GeneChips as described for cDNA. Results
from duplicate samples were averaged.
Data were analyzed with Affymetrix Microarray Suite 5.0 software
package. The numerical signal intensity for each probe set was used for
further calculation in Microsoft Excel and R (www.r-project.org). The SAM
program (Tusher et al., 2001) was used at the threshold value of 0.05.
Quantitative RT-PCR
Mouse diaphragms were stained with rBTX as in Microarray analysis and
divided into synapse-rich and -free segments (Merlie and Sanes, 1985). To-
tal RNA was extracted, and 1- g aliquots were used for cDNA synthesis.
Products were used for quantitative RT-PCR using the TaqMan 7700 Se-
quence Detection System (PerkinElmer) and SYBER-GREEN dye (Applied Bio-
systems) as described previously (Wittwer et al., 1997; Morrison et al.,
1998). Levels of GAPDH RNA were used for normalization. Assays were re-
peated on two independently prepared samples, and each sample was as-
sayed in duplicate.
Antibody production
A fragment of LL5  corresponding to aa 418–760 was fused to a polyhis-
tidine epitope tag, expressed in Escherichia coli, purified with Ni-NTA
Spin Kit (QIAGEN), and used to immunize BalbC mice. Hybridomas were
produced by standard methods, and their products were assayed by
ELISA, using immobilized immunogen, and by immunostaining of COS
cells transfected with a GFP-LL5  fusion. Three mAbs (1H12, 6B9, and
7E3) were subcloned.
Evidence that these antibodies specifically recognize LL5  is as fol-
lows: (a) the antibodies stain COS cells transfected with LL5  but not un-
transfected cells (Fig. S1 B, available at http://www.jcb.org/cgi/
content/full/jcb.200411012/DC1). (b) Antibody staining patterns of un-
transfected muscle fibers match GFP fluorescence patterns in muscle fibers
transfected with the LL5 -GFP fusion (compare Figs. 4 B and 5 A). (c)
There is a similar correspondence for cultured muscle cells. (d) Two of the
three antibodies (7E3 and 1H12) detect a single band on immunoblots of
C2 myotube lysates (Fig. S1 A). This is the expected size for LL5 . Results
using antibody 1H12 (IgG1 subclass) are shown here, but similar results
were obtained with 6B9 and 7E3.
Histology
Whole mount in situ hybridization was performed as described by Wilkin-
son and Nieto (1993) using digoxygenin-labeled cRNA probes. Digoxy-
genin was detected with alkaline phosphatase-conjugated anti-digoxyge-
nin antibody (Roche), and signal was developed with NBT plus BCIP.
For immunohistochemistry, mouse or rat muscles were fixed in 1%
PFA, sunk in 30% sucrose/PBS, frozen, and sectioned at 10  m in a cryo-
stat. Sections were stained sequentially with anti-LL5  and a mixture of
Alexa 488–conjugated secondary antibody and rBTX or Alexa 596–BTX
(Molecular Probes).
Electroporation in vivo
Mouse LL5  cDNA was obtained from American Type Culture Collection
(IMAGE clone 6405379). Full-length and PH domain–deleted coding se-
quences (lacking aa 1194–1302) were amplified by RT-PCR and ligatedLOCALLY TRANSLATED SYNAPTIC COMPONENTS • KISHI ET AL. 365
to the BglII–SalI site of pEGFP-C1 vector (CLONTECH Laboratories, Inc.).
Inserts were sequenced. Plasmids were introduced into tibialis muscles of
P10 mice by electroporation as described by Grady et al. (2003). 4 d af-
ter electroporation, muscles were dissected under a fluorescent stereomi-
croscope, fixed in 4% PFA, counterstained with BTX, and imaged with a
confocal laser scanning microscope (model FV500; Olympus) using a
100  oil objective (NA 1.40).
Tissue culture
C2C12 myoblasts (American Type Culture Collection) were plated on Lab-
tek 8-well Permanox chamber slides (Nalge) coated with 0.2% gelatin
(Bio-Rad Laboratories) or 10  g/ml laminin-1 (Invitrogen) as described by
Kummer et al. (2004). Where indicated, myoblasts were transfected on
the day of plating using FuGENE6 (Roche). One day after plating, cultures
were switched to DME plus 2% horse serum to induce fusion. Cultured myo-
tubes were stained live with 1  g/ml rBTX for 30 min, and then fixed, per-
meabilized, and stained with anti-LL5  and anti-GFP (Chemicon). Images
collected with a CCD camera (model MagnaFire; Optronics) were ana-
lyzed with Metamorph software (Universal Imaging Corp.).
To suppress LL5  expression, siRNA sequences were selected using
SVM RNAi software (Chang Bioscience), siRNA DESIGN Center (Dharma-
con), and the siRNA Selection Server at the Whitehead Institute (Massa-
chusetts Institute of Technology, Cambridge, MA; http://jura.wi.mit.edu/
siRNAext/). The mouse genome was searched with selected sequences to
ensure their specificity. RNA duplexes of the following target sequences
were purchased from Dharmacon: No. 1, AACCUCCUAUUUCUUUC-
CUCA; No. 2, AAGCCUAAGACAGUCGUCAGA; No. 3, AAGACUUG-
GAAUUCCAGCAGC; and No. 4, AAGCAAGCCAGUCACAUCGUU.
COS-7 cells were cotransfected with an expression vector encoding GFP-
LL5  plus one of these RNAs, or control duplexes VII (57% GC Content) or
VIII (52% GC Content; Dharmacon), using Lipofectamine 2000 (Invitro-
gen). RNAs Nos. 1 and 2 suppressed expression of GFP-LL5  dramati-
cally; RNA No. 4 had a less dramatic effect; and RNA No. 3 and control
duplexes VII and VIII had no obvious effect on GFP-LL5  expression. RNAs
Nos. 1, 2, and 4 had no effect on expression of GFP alone, indicating
that their effects were specific; the susceptibility of GFP cDNA to RNAi
suppression was demonstrated with RNAi specific for GFP.
Based on these results, sequences of RNA Nos. 1 and 2 and GFP
RNAi were cloned into a plasmid-based siRNA-expression system (pSuper
vector; Oligoengine). Plasmids were used rather than oligonucleotides be-
cause they were superior for maintaining high expression of the interfering
sequences throughout the week-long culture period. Myotubes were trans-
fected at the time of plating using FuGene6 reagent (Roche) according to
manufacturer’s instructions. A total of 6.6  l FuGene reagent and 2.2  g
DNA in 100  l DME was used to transfect every two wells of an 8-well
chamber slide. Cells were switched to differentiation medium 1 d after
transfection and cultured for an additional 5–6 d. Cells were then stained
live with a fluorescent conjugate of BTX plus, where appropriate, anti-GFP.
Online supplemental material
Fig. S1 shows evidence for specificity of anti-LL5  antibodies. Table S1
shows the ratio of synaptic to extrasynaptic signal for each synaptic gene
from each microarray experiment. These ratios were then ranked to give
the values presented in Table I. Table S2 shows transcripts enriched
greater than threefold in synaptic compared with extrasynaptic samples.
Rankings and ratios, calculated as in Table I and Table S1, respectively,
are shown, along with UniGene number (http://www.ncbi.nlm.nih.gov)
and gene name. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.200411012/DC1.
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